赖氨酰氧化酶
信使核糖核酸
糖皮质激素
前胶原肽酶
体内
Ⅰ型胶原
内分泌学
人体皮肤
倍他米松
基质金属蛋白酶
化学
内科学
分子生物学
生物
酶
生物化学
医学
基因
生物技术
遗传学
作者
Oikarinen,Haapasaari,Sutinen,Kaisa Tasanen
标识
DOI:10.1046/j.1365-2133.1998.02646.x
摘要
The effects of topical betamethasone-17-valerate on collagen propeptide levels, collagen mRNA level, lysyl oxidase mRNA and matrix metalloproteinase (MMP)-1 and MMP-2 mRNA levels were studied in human skin. Three days' treatment of healthy skin with topical betamethasone caused a 70-80% decrease in type I and III collagen propeptides in suction blister fluid. A similar decrease was found in type I collagen mRNA when assayed by either slot-blot hybridization or a quantitative polymerase chain reaction method, indicating that the decrease in collagen synthesis after topical glucocorticoid treatment is apparently due to a decrease in corresponding mRNA. mRNA of lysyl oxidase, which is an important enzyme catalysing the cross-linking of collagen chains, and collagen-degrading enzyme MMP-1 and MMP-2 mRNAs were not decreased in the same skin samples. This suggests that in vivo, glucocorticoids modulate variably the genes involved in collagen synthesis and degradation. Our study provides a solid molecular basis for glucocorticoid-induced dermal atrophy, which results from the decrease in functional collagen mRNA in the skin.
科研通智能强力驱动
Strongly Powered by AbleSci AI